课题基金 / 基金详情

Psychosocial Stress-Induced Vascular Contributions to Cognitive Impairment and Alzheimer's Disease: The Role of Xanthine Oxidase

Psychosocial Stress-Induced Vascular Contributions to Cognitive Impairment and Alzheimer's Disease: The Role of Xanthine Oxidase
心理社会压力诱发的血管对认知障碍和阿尔茨海默病的影响:黄嘌呤氧化酶的作用
批准号:
10206431
负责人:
Paul D Chantler
金额:
$51.81万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-09-15 至 2021-08-31

项目摘要

项目成果

Paul D Chantler的其他基金

相关文献

中文摘要
翻译
项目总结/摘要 血管对认知障碍和痴呆的贡献(VCID)是痴呆的第二大原因 阿尔茨海默氏病(AD)的背后,并且是AD的常见共病。此外, 与AD病理学结合的血管病理学导致痴呆的可能性增加。尽管 VCID的重要性,但其在血管和认知功能方面的分子机制知之甚少 功能障碍这使得NIH优先研究血管对痴呆的贡献, 与AD相互作用慢性心理社会应激是VCID的危险因素。我们的初步数据显示, 应激导致相当大的脑血管和神经炎性变化,这些变化具有类似的基础 AD进展中的明显变化使我们关注这一过程。内皮功能障碍是一个关键的 血管疾病的决定因素和临床事件的预测因素。黄嘌呤氧化还原酶(XOR)是一种主要的 氧化产物(过氧化氢和超氧化物)和尿酸的来源。肝脏是最大的 异或运算和循环异或运算的主要来源。因此,XOR可能对脉管系统产生负面影响。 我们的初步数据表明,慢性应激增加XOR活动,导致脑血管功能障碍 以及导致认知障碍的神经炎症增加。我们的核心假设是慢性压力 升高肝脏XOR,其释放到循环中直接引起脑血管功能障碍, 通过TLR 4途径激活神经炎症,导致认知能力下降, 痴呆/AD病理学。目的1使用肝脏(肝细胞)特异性XOR条件性KO(HXdh-/-)小鼠和 肝脏特异性XOR过表达工具在8周慢性应激期间操纵XOR通路, 检查VCID的病理。在目标2中,我们将使用TLR 4-/-小鼠,沿着生理和 药理学方法来操纵TLR 4/NF-κB通路,再次在慢性应激和 确定VCID病理。在目标3中,我们将使用慢性应激增加XOR活性,并将其转换为 通过补充亚硝酸盐,观察其对一氧化氮的不良氧化产物,并测定其在病理上的作用。 VCID。补充实验还将通过操纵XOR来检查VCID和AD的相互作用 途径(使用非布司他或亚硝酸盐),并确定我们是否可以延迟AD的病理进展(3xTg- AD小鼠)。试点数据支持这一假设。因此,这些研究的总体目标是确定病因 应激相关的XOR和促炎性变化介导VCID,及其进展到AD病理。 这些研究将填补美国国立卫生研究院确定的关于需要了解血管对 认知障碍和痴呆。
英文摘要
PROJECT SUMMARY / ABSTRACT Vascular contributions to cognitive impairment and dementia (VCID) is the second leading cause of dementia behind Alzheimer's disease (AD), and is a frequent co-morbidity with AD. Furthermore, the deleterious effect of vascular pathologies combined with AD pathology leads to increased likelihood of dementia. Despite the importance of VCID, little is known about its molecular mechanisms underlying vascular and cognitive dysfunction. This has led the NIH to prioritize studies examining vascular contributions to dementia, and its interplay with AD. Chronic psychosocial stress is a risk factor of VCID. Our preliminary data showing that chronic stress leads to considerable cerebrovascular and neuroinflammatory changes that have similar fundamental changes evident in the progression of AD has led us to focus on this process. Endothelial dysfunction is a critical determinant of vascular disease and predictor of clinical events. Xanthine oxidoreductase (XOR) is a major source of oxidative products (hydrogen peroxide and superoxide) and uric acid. The liver is the site of greatest XOR activity and the main source of circulating XOR activity. As such, XOR can negatively affect the vasculature. Our preliminary data suggest that chronic stress increases XOR activity resulting in cerebrovascular dysfunction and increased neuroinflammation leading to cognitive impairment. Our central hypothesis is that chronic stress elevates hepatic XOR, which is released into the circulation directly causing cerebrovascular dysfunction and the activation of neuroinflammation via a TLR4 pathway resulting in cognitive decline which accelerates dementia/AD pathology. Aim 1 uses a liver (hepatocyte)-specific XOR conditional KO (HXdh-/-) mouse and a liver-specific XOR overexpression tool to manipulate the XOR pathway during 8 weeks of chronic stress and to examine the pathology of VCID. In Aim 2, we will uses the TLR4-/- mouse, along with physiological and pharmacological approaches to manipulate the TLR4/NF-κB pathway, again in the context of chronic stress and determine VCID pathology. In Aim 3, we will use the increase in XOR activity with chronic stress and switch its bad oxidative products to nitric oxide by supplementing with nitrite and determine its actions on the pathology of VCID. Complementary experiments will also examine the interaction of VCID and AD, by manipulating the XOR pathway (using febuxostat or nitrite) and determining if we can delay the pathological progression of AD (3xTg- AD mice). Pilot data support this hypothesis. Thus, the overall goal of these studies is to determine the etiology of the stress-related XOR and pro-inflammatory changes in mediating VCID, and its progression to AD pathology. The studies will fill gaps identified by the NIH regarding the need for understanding of vascular contributions to cognitive impairment and dementia.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Psychosocial Stress-Induced Vascular Contributions To Cognitive Impairment And Alzheimer's Disease: The Role of Xanthine Oxidase
  • 批准号:
    10669630
  • 项目类别:
  • 资助金额:
    $50.08万
  • 财政年份:
    2021
  • 负责人:
    Paul D Chantler
  • 依托单位:
Psychosocial Stress-Induced Vascular Contributions To Cognitive Impairment And Alzheimer's Disease: The Role of Xanthine Oxidase
  • 批准号:
    10470769
  • 项目类别:
  • 资助金额:
    $50.76万
  • 财政年份:
    2021
  • 负责人:
    Paul D Chantler
  • 依托单位:
Psychosocial Stress-Induced Vascular Contributions To Cognitive Impairment And Alzheimer's Disease: The Role of Xanthine Oxidase
  • 批准号:
    10205539
  • 项目类别:
  • 资助金额:
    $50.76万
  • 财政年份:
    2021
  • 负责人:
    Paul D Chantler
  • 依托单位:
Psychosocial Stress-Induced Vascular Contributions To Cognitive Impairment And Alzheimer's Disease: The Role of Xanthine Oxidase
  • 批准号:
    10621570
  • 项目类别:
  • 资助金额:
    $5.36万
  • 财政年份:
    2021
  • 负责人:
    Paul D Chantler
  • 依托单位: